Torrent Pharma has announced that its merger with JB Chemicals is in the final phase and is expected to be completed within one to two months. The merged entity plans to concentrate on bolstering its business operations in India, viewing the domestic market as a crucial factor for sustained long-term growth. This strategic focus aligns with the companies' commitment to enhancing their footprint in the Indian pharmaceutical sector, which remains a significant growth opportunity. The merger is anticipated to create a stronger combined company positioned to better serve the Indian market. Merged entity would focus more on strengthening the India business, which it sees as the key long-term growth driver, the company said.